RecruitingNCT07460141

IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients

The Effects of IL-6 and Inflammation Scores on Mortality in Postoperative Patients Admitted to the Intensive Care Unit

Sponsor

Ezgi Günaydın

Enrollment

42 participants

Start Date

Dec 15, 2025

Study Type

OBSERVATIONAL

Conditions

Postoperative Complications Inflammation Critical Illness Intensive Care Unit Admission

Summary

This prospective observational cohort study aims to evaluate the predictive value of interleukin-6 (IL-6) levels and hemogram-derived inflammatory scores for morbidity and in-hospital mortality in postoperative patients admitted to the intensive care unit (ICU). IL-6 levels and inflammatory indices will be assessed at ICU admission and at 24 hours using data obtained from routine clinical care. Associations between these biomarkers and clinical outcomes, including mortality, morbidity, antibiotic use, and duration of mechanical ventilation, will be evaluated after adjustment for illness severity.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether certain blood test results taken after surgery can help predict which ICU patients are at higher risk of dying. Researchers are studying a protein called IL-6 and other inflammation markers in the blood of patients recovering from surgery in the intensive care unit. **You may be eligible if...** - You are 18 years old or older - You were admitted to the ICU after surgery - You have complete medical and lab records available at ICU admission and 24 hours later - You or a family member can provide informed consent **You may NOT be eligible if...** - You are under 18 years old - You had chest (thoracic) surgery - You had heart surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.